Top Markets
#1 ADO Protocol ADO Protocol +195.93%
#2 Islamic Coin Islamic Coin +155.37%
#3 GoPlus Security GoPlus Security +59.90%
#4 Starpower Starpower +25.13%
#5 GAIB AID GAIB AID +24.67%
#6 The Black Bull The Black Bull +15.10%
#7 Casper Network Casper Network +14.54%
#8 Verus Coin Verus Coin +13.55%
#9 Status Status +12.46%
#10 o1.exchange o1.exchange +10.83%
Coin of the day
ADO Protocol ADO Protocol
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
NeoImmuneTech, Inc. NeoImmuneTech, Inc.

NeoImmuneTech, Inc.

950220
Clasificación en acciones #33508
As a clinical-stage biotechnology firm with a strong focus on T cells,... As a clinical-stage biotechnology firm with a strong focus on T cells, NeoImmuneTech, Inc. is dedicated to creating and marketing innovative immunotherapies. The company's lead product, NT-I7, is a long-acting human IL-7 currently in clinical development for its potential to treat a range of oncologic and infectious conditions. Founded in 2014, NeoImmuneTech is based in Rockville, Maryland.
Precio por acción
$1.12
Última sincronización: 2026-08-14
Capitalización bursátil
$7.52M
Cambio (1 día)
4.51%
Cambio (1 año)
-94.79%
País
US
Comercio NeoImmuneTech, Inc. (950220)

Categoría

Healthcare
Ratio P/S de NeoImmuneTech, Inc. (950220)
Ratio P/S al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de NeoImmuneTech, Inc., el ratio P/S actual (TTM) es 0. Al final de 2026, el ratio P/S era 0.
Historial del ratio P/S de NeoImmuneTech, Inc. desde 2026 hasta 2026
Ratio P/S al final de cada año
Año Ratio P/S Cambiar
Not enough data for the provided dates.
Ratio P/S de empresas similares o competidoras
Empresa Ratio P/S Diferencia del ratio P/S País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
4.74 -
BE